Germany Archives

paion surgery Remimazolam cardiac colonoscopy praion

News and Trends 22 Feb 2016

This German Biotech had to stop its EU Phase III Trial for Lack of Recruitment

The Aachen-based pharma Paion (Germany), has been forced to axe a European phase III trial for a Surgical sedative, after failing to recruit enough patients. The company will instead focus its efforts on its ongoing US trials. This is a blow to Paion’s pipeline, which is led by Remimazolam. The company stock price decreased almost 40%, but it […]

February 22, 2016 - 3 minutesmins - By Denise Neves Gameiro

DIRK BUSCH TECHNICAL UNIVERSITY MUNICH car t leukemia all

News and Trends 17 Feb 2016

Cancer: World Best Ever CAR-T Results have Just been Disclosed

These are the best results yet for CAR-T, this time from a research group led by Dirk Busch at the Technical University of Munich (Germany). In part backed by Juno Therapeutics, a method to select more potent T-cells and engineer a safety mechanism was announced at the annual meeting of the AAAS in Washington (US). CAR-T therapies are one of the ways […]

February 17, 2016 - 3 minutesmins - By Denise Neves Gameiro

apogenix glioblastoma cancermark german apg101

News and Trends 17 Feb 2016

Brain Cancer Biomarker is a Magnet for Public Money in Germany

Apogenix (Germany) has been granted €3M for a personalized medicine to treat glioblastoma. It will also use this funding to develop a companion diagnostic test using a specific cancer biomarker, which other German biotechs are also attempting to do… This Heidelberg based-biotech (which we visited on our Labiotech tour of South Germany) is focused on the development of protein Immuno-Oncology therapeutics to treat […]

February 17, 2016 - 3 minutesmins - By Dani Bancroft

News and Trends 16 Feb 2016

The Only Real European Biotech Unicorns in 2016

Unicorns are private fast-growing companies valued more than a billion euro/dollars. This club is getting bigger and bigger, 146 companies while I’m writing this article (look at the full list on the Wall Street Journal). There is a very reduced number of Biotech unicorns worldwide and even less in Europe. There are actually only 3: […]

February 16, 2016 - 3 minutesmins - By Philip Hemme

News and Trends 15 Feb 2016

Celebrating the 10th Birthday of this German Infectious Disease Biotech with the CEO

AiCuris is a Biotech company based on the Bayer Life Sciences park in Wuppertal (Germany). It is working on new anti-infective drugs and is a former spin-off of Germany’s biggest Pharma Company. It’s celebrating its 10th birthday this year, which is good reason to interview the CEO… So AiCuris is working on anti-infective drugs for […]

February 15, 2016 - 4 minutesmins - By Philip Hemme

News and Trends 8 Feb 2016

The European Union Finances the Future of CAR-T Manufacturing

CAR-T is the way forward in Cancer therapeutics, which is one of the leading causes of Mortality in the Western world. Now this European consortium has amassed €6M for a more unified approach to CAR-T under a European Union Commission program. In response to this major health issue Miltenyi Biotec (Germany) coordinates the new EU-funded project […]

February 8, 2016 - 3 minutesmins - By Dani Bancroft

riboxx life sciences rna cancer tollys biotech

News and Trends 5 Feb 2016

German RNA Specialist Could Break French Biotech into the Cancer Ecosystem

Riboxx Life Sciences (Germany) has licensed out its drug development platform APOXXIM to a small biotech, Tollys SAS in Lyon (France) to investigate a specific type of cancer therapy. Riboxx develops customized and tailor-made molecular tools for gene silencing in vitro and in vivo through RNA interference via small interfering RNA (siRNA) and microRNA (miRNA). The company has two […]

February 5, 2016 - 2 minutesmins - By Dani Bancroft

msd cancer research uk monash crt merck australia

News and Trends 1 Feb 2016

New Discovery unites Australia, Germany and UK Against Blood Cancers

Cancer Research UK has teamed up with MSD (Merck) and the Wellcome Trust to co-develop some Inhibitors for both Cancerous and Non-cancerous blood disorders from the Australian Academia-Biotech Network. The Australian Co-operative Research Centre (CRC) for Cancer Therapeutics (CTx) in Melbourne has a range of investigational inhibitors for blood disorders – including Leukemia. CTx is collaborative partnership […]

February 1, 2016 - 2 minutesmins - By Dani Bancroft

merck msd keytruda immunoncology lymphoma hodgkins affimed

News and Trends 26 Jan 2016

Keytruda Combo! MSD Recruits German Biotech on Lymphoma PD-1 Trial

Affimed in Heidelberg (Germany) will fund and conduct a clinical trial to investigate the combination of Merck’s (MSD) anti-PD-1 therapy (Keytruda), with Affimed’s proprietary drug for the treatment of patients with Hodgkin lymphoma. The phase Ib trial will focus on patients whose disease has relapsed or is refractory to chemotherapy, including treatment with the marketed antibody-drug-conjugate […]

January 26, 2016 - 2 minutesmins - By Dani Bancroft

open evolution machine biohacking turbidostat johann bauerfeind digital

News and Trends 25 Jan 2016

Nature’s Machines: Biohacking Evolution to Destroy Pollutants

The Concept of artificially ‘Driving Evolution’ is as contagiously controversial as it is captivating for Biotechs, DIY Biologists and iGEM teams alike. How can we harness an ‘Evolution Machine’ for the Greener Good and ‘create’ microbes to break down pollutants? At the Digital Biology (“Do it Together”) Conference last week (a European consortium for DIY Biologists and […]

January 25, 2016 - 5 minutesmins - By Dani Bancroft

md anderson mologen cancer lung colorectal

News and Trends 21 Jan 2016

Mologen Joins the Rapidly Growing List of EU Partners with the No#1 US Cancer Hospital

MD Anderson (US) and the Berlin Biotech Mologen (Germany) have now partnered on for an Immuno-Oncology program fighting colorectal and small-cell lung carcinoma. The University of Texas MD Anderson Cancer Center is ‘One of the world’s most respected centres‘ devoted exclusively to cancer patient care, research, education and prevention. Having partnered with various European research institutions, medical centres […]

January 21, 2016 - 2 minutesmins - By Dani Bancroft

$jp morgan biotech conference san fracisco morphosys$

News and Trends 18 Jan 2016

Inside Biotech’s Most Secretive Elite Conference: MorphoSys Talks on Investor Speed Dating in California

MorphoSys is the Biggest Biotech in Germany, and second biggest in Europe – so it is no wonder they were selected for access to the exclusive J.P.Morgan Conference in San-Francisco last week. Here, the MorphoSys team, which included Claudia Gutjahr-Löser and the CEO Simon Moroney, give you a sneak-insiders look into one of the most elite Biotech […]

January 18, 2016 - 4 minutesmins - By Philip Hemme

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Germany

This German Biotech had to stop its EU Phase III Trial for Lack of Recruitment

Cancer: World Best Ever CAR-T Results have Just been Disclosed

Brain Cancer Biomarker is a Magnet for Public Money in Germany

The Only Real European Biotech Unicorns in 2016

Celebrating the 10th Birthday of this German Infectious Disease Biotech with the CEO

The European Union Finances the Future of CAR-T Manufacturing

German RNA Specialist Could Break French Biotech into the Cancer Ecosystem

New Discovery unites Australia, Germany and UK Against Blood Cancers

Keytruda Combo! MSD Recruits German Biotech on Lymphoma PD-1 Trial

Nature’s Machines: Biohacking Evolution to Destroy Pollutants

Mologen Joins the Rapidly Growing List of EU Partners with the No#1 US Cancer Hospital

Inside Biotech’s Most Secretive Elite Conference: MorphoSys Talks on Investor Speed Dating in California

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!